Published in Mo Med on November 27, 2013
Electroacupuncture Treatment Improves Learning-Memory Ability and Brain Glucose Metabolism in a Mouse Model of Alzheimer's Disease: Using Morris Water Maze and Micro-PET. Evid Based Complement Alternat Med (2015) 0.84
mNos2 deletion and human NOS2 replacement in Alzheimer disease models. J Neuropathol Exp Neurol (2014) 0.78
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci (2009) 3.68
Resting state functional connectivity of the striatum in Parkinson's disease. Brain (2012) 2.53
Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem (2012) 2.42
Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J Biol Chem (2008) 2.34
Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J Neurosci (2012) 2.26
Neurologic complications of HIV disease and their treatment. Top HIV Med (2010) 2.14
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci (2011) 2.00
Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet (2007) 1.95
The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Proc Natl Acad Sci U S A (2005) 1.89
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A (2013) 1.88
Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology (2013) 1.82
Temporal dynamics of brain tissue nitric oxide during functional forepaw stimulation in rats. Neuroimage (2003) 1.67
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. JAMA Neurol (2013) 1.60
HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Technology insight: can neuroimaging provide insights into the role of ischemia in Baló's concentric sclerosis? Nat Clin Pract Neurol (2007) 1.57
Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurol (2013) 1.51
Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem (2010) 1.47
A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron (2003) 1.45
Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem (2006) 1.41
Non-competitive androgen receptor inhibition in vitro and in vivo. Proc Natl Acad Sci U S A (2009) 1.37
Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation. Mol Cell Biol (2008) 1.35
Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice. Neurobiol Dis (2009) 1.16
Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology (2013) 1.16
Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14
Baló's concentric sclerosis presenting as a stroke-like syndrome. Nat Clin Pract Neurol (2007) 1.14
Biologically active molecules that reduce polyglutamine aggregation and toxicity. Hum Mol Genet (2006) 1.14
Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Med (2013) 1.10
Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract. Endocrinology (2006) 1.04
A cellular conformation-based screen for androgen receptor inhibitors. ACS Chem Biol (2008) 1.03
Cellular mechanisms of protein aggregate propagation. Curr Opin Neurol (2012) 1.01
Impaired and facilitated functional networks in temporal lobe epilepsy. Neuroimage Clin (2013) 1.01
FLAIR vascular hyperintensity may predict stroke after TIA. Clin Neurol Neurosurg (2007) 0.99
Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum Mol Genet (2013) 0.99
An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem (2013) 0.99
ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation. FEBS Lett (2008) 0.98
Alzheimer disease family history impacts resting state functional connectivity. Ann Neurol (2012) 0.97
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol (2013) 0.96
Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 0.96
Neuroimaging markers of human immunodeficiency virus infection in South Africa. J Neurovirol (2012) 0.95
Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol (2013) 0.95
Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci (2012) 0.95
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol (2007) 0.94
The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS (2012) 0.93
Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc Natl Acad Sci U S A (2009) 0.93
A common motif targets huntingtin and the androgen receptor to the proteasome. J Biol Chem (2008) 0.92
Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS (2011) 0.91
F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics. PLoS One (2010) 0.90
AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization. ACS Chem Biol (2009) 0.90
Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies. Appl Radiat Isot (2005) 0.90
A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need? AIDS (2015) 0.90
Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol (2014) 0.90
Design and implementation of cell-based assays to model human disease. ACS Chem Biol (2007) 0.89
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas. J Nucl Med (2013) 0.89
Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. J Med Chem (2002) 0.89
HIV clades B and C are associated with reduced brain volumetrics. J Neurovirol (2013) 0.88
Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET. PLoS One (2013) 0.88
Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. J Med Chem (2007) 0.88
Radiolabeled amino acids for oncologic imaging. J Nucl Med (2013) 0.88
Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics (2013) 0.88
Luminance contrast of a visual stimulus modulates the BOLD response more than the cerebral blood flow response in the human brain. Neuroimage (2012) 0.87
Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect (2014) 0.86
The expanding realm of prion phenomena in neurodegenerative disease. Prion (2009) 0.86
Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease. PLoS One (2013) 0.86
Cerebral white matter integrity during primary HIV infection. AIDS (2015) 0.85
Fluorine-18 labeled amino acids for oncologic imaging with positron emission tomography. Curr Top Med Chem (2013) 0.85
An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors. Hum Mol Genet (2011) 0.84
Central nervous system complications of HIV infection. Top Antivir Med (2011) 0.84
Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity. AIDS (2015) 0.83
Impact of human immunodeficiency virus on neurocognition and risky behaviors in young adults. J Neurovirol (2014) 0.82
Comparison of regional cerebral blood flow responses to hypoglycemia using pulsed arterial spin labeling and positron emission tomography. PLoS One (2013) 0.81
Diagnosis and evaluation of a patient with rapidly progressive dementia. Mo Med (2013) 0.81
Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Nucl Med Biol (2005) 0.80
Coupling of cerebral blood flow and oxygen metabolism is conserved for chromatic and luminance stimuli in human visual cortex. Neuroimage (2012) 0.80
Imaging evaluation of CSF shunts. AJR Am J Roentgenol (2014) 0.79
Amyotrophic lateral sclerosis and organ donation: is there risk of disease transmission? Ann Neurol (2012) 0.79
Neurologic complications of HIV infection: highlights from the 2013 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med (2013) 0.79
Neurologic complications of HIV infection. Top Antivir Med (2012) 0.79
The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals. J Neuroimmune Pharmacol (2015) 0.79
Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging. Nucl Med Biol (2013) 0.78
Protein phosphatase 1 dephosphorylates profilin-1 at Ser-137. PLoS One (2012) 0.77
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76
The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Alzheimer Dis Assoc Disord (2014) 0.76
Tumefactive demyelination in a patient with human immunodeficiency virus. J Neurovirol (2013) 0.75
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One (2016) 0.75
Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era. J Acquir Immune Defic Syndr (2017) 0.75
Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS (2016) 0.75
Susac syndrome in a patient with human immunodeficiency virus infection. J Neurovirol (2013) 0.75
A strong consensus has emerged around the role of protein misfolding and aggregation in the pathogenesis of neurodegeneration. Introduction. Neurotherapeutics (2013) 0.75
Nuclear medicine in the acute clinical setting: indications, imaging findings, and potential pitfalls. Radiographics (2013) 0.75
Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord (2017) 0.75
Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients. J Acquir Immune Defic Syndr (2017) 0.75
Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands. J Med Chem (2005) 0.75
Fluorine-containing drugs as PET diagnostics (F-18 labeled tracers). Curr Top Med Chem (2013) 0.75